Usana Health Stock Hits New 52-Week High (USNA)

NEW YORK ( TheStreet) -- Usana Health (NYSE: USNA) hit a new 52-week high Monday as it is currently trading at $38.56, above its previous 52-week high of $38.50 with 50,112 shares traded as of 12:34 p.m. ET. Average volume has been 64,200 shares over the past 30 days.

Usana Health has a market cap of $506.1 million and is part of the health care sector and drugs industry. Shares are up 23.2% year to date as of the close of trading on Friday.

USANA Health Sciences, Inc. develops, manufactures, distributes, and sells nutritional and personal care products worldwide. It offers two product lines, USANA Nutritionals and Sense. The company has a P/E ratio of 11.6, above the average drugs industry P/E ratio of 10.8 and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Usana Health as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels, solid stock price performance and growth in earnings per share. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. You can view the full Usana Health Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.